Transcripts Q32 Bio Inc.

Equities

QTTB

US7469641051

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-26 pm EDT			5-day change	1st Jan Change
28.02 ^USD	-0.78%		+24.59%	+156.03%

Apr. 11	Oppenheimer Initiates Coverage on Q32 Bio With Outperform Rating, $50 Price Target	MT
Apr. 03	Q32 Bio Inc. Appoints Lee Kalowski as Chief Financial Officer	CI

Transcripts

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Transcript : Homology Medicines, Inc. - Special Call	23-07-27
Transcript : Homology Medicines, Inc. - Special Call	22-05-18
Transcript : Homology Medicines, Inc. - Special Call	22-01-28
Transcript : Homology Medicines, Inc. Presents at 30th Annual Credit Suisse Healthcare Conference, Nov-08-2021 10:30 AM	21-11-08
Transcript : Homology Medicines, Inc. Presents at BofA Napa Healthcare Conference, Jun-15-2021 12:30 PM	21-06-15
Transcript : Homology Medicines, Inc. - Special Call	21-05-13
Transcript : Homology Medicines, Inc. - Special Call	21-01-05
Transcript : Homology Medicines, Inc. - Special Call	20-11-06
Transcript : Homology Medicines, Inc. - Shareholder/Analyst Call	20-06-10
Transcript : Homology Medicines, Inc. Presents at BofA Securities 2020 Health Care Conference, May-12-2020 11:00 AM	20-05-12
Transcript : Homology Medicines, Inc. - Special Call	19-12-17
Transcript : Homology Medicines, Inc. Presents at Bank of America Merrill Lynch 2019 Healthcare Conference, May-14-2019 through May-16-2019	19-05-14

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+39.41% on our US portfolio vs. 25.67% on the S&P 500 net Total Return

Replicate our performance

fermer